Genomics Core to Have a Principal Role in the UMass Boston/DFHCC U54 Cancer Research Partnership

CPCT | October 21, 2016
Genomics Core to Have a Principal Role in the UMass Boston/DFHCC U54 Cancer Research Partnership

Image by: Christian Arthur

UMass Boston and Dana-Farber/Harvard Cancer Center have been granted $8.5M over five years in support of the U54 Comprehensive Partnership for Cancer Disparities Research program. Drs. Adan Colón-Carmona (associate professor of biology) and Jill Macoska (director, CPCT) are the UMass Boston principal and co-principal investigators respectively. The CPCT’s own Genomics Core will serve as a training ground for many UMass Boston students interested in cancer research. Check out the full story here.

Tags: biology , cancer , center for personalized cancer therapy , cpct , genomics core , genomics core facility , research , science , u54 , umass boston-dana farber harvard cancer center

Comments not allowed for this story